MET alterations in advanced non-small cell lung cancer

被引：8
|
作者：
Sakamoto, Mandy [1 ]
Patil, Tejas [1 ,2 ]
机构：
[1] Dept Med, Div Med Oncol, Aurora, CO USA
[2] Univ Colorado, Canc Ctr, 1665 Aurora Court,MS F704, Aurora, CO 80045 USA
来源：
LUNG CANCER | 2023年 / 178卷
关键词：
NSCLC; MET alterations; MET amplification; MET overexpression; HEPATOCYTE GROWTH-FACTOR; EXON; 14; MUTATIONS; GENE COPY NUMBER; PREVIOUSLY TREATED PATIENTS; TYROSINE KINASE INHIBITORS; TIVANTINIB ARQ 197; PHASE-II; C-MET; ACQUIRED-RESISTANCE; SKIPPING ALTERATIONS;
D O I：
10.1016/j.lungcan.2023.02.018
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Targeting the MET pathway in advanced NSCLC has been of particular interest due to its role as both a primary oncogenic driver and secondary oncogenic driver of acquired resistance. Activation of the MET pathway can occur through several mechanisms, which can complicate the diagnostic and treatment approach. Recently, several MET-directed therapies have been developed with promising results. In this narrative review, we sum-marize the biology and mechanism of MET as a clinically relevant driver mutation, distinct MET alterations including diagnostic challenges, significance in the setting of acquired resistance, and novel treatment strategies in advanced NSCLC.
引用
收藏
页码：254 / 268
页数：15
相关论文
共 50 条
  • [1] MET alterations in advanced non-small cell lung cancer
    Chagas, Gabriel Cavalcante Lima
    Rangel, Amanda Ribeiro
    El Osta, Badi
    [J]. CURRENT PROBLEMS IN CANCER, 2024, 49
  • [2] The Landscape of MET Alterations in Chinese Non-Small Cell Lung Cancer Patients
    Zheng, M.
    Jun, P.
    Wang, S.
    Li, M.
    Mao, N.
    Liu, Y.
    Cheng, T.
    Lan, H.
    Zhao, J.
    Wang, W.
    Hu, J.
    Yao, M.
    Wang, K.
    Qu, Y.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S567 - S567
  • [3] Comprehensive characterization of MET alterations in a large cohort of 610 advanced non-small cell lung cancer patients
    Aguado Esteban, Cristina
    Teixido, Cristina
    Roman, Ruth
    Gimenez Capitan, Ana Maria
    Cabrera, Carlos
    Garcia, Mireia
    De Las Casas, Clara D. Mayo
    Arcocha, Ainara
    Rodriguez, Sonia
    Reyes, Roxana
    Marin, Elba
    Perez Rosado, Ana
    Karachaliou, Niki
    Prat, Aleix
    Rosell, Rafael
    Martinez-Bueno, Alejandro
    Angel Molina-Vila, Miguel
    Reguart, Noemi
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [4] C-MET inhibitors for advanced non-small cell lung cancer
    Pasquini, Giulia
    Giaccone, Giuseppe
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2018, 27 (04) : 363 - 375
  • [5] Genetic MET alterations in non-small cell lung cancer: biologic differences and analogies
    Castiglione, R.
    Alidousty, C.
    Wagener, S.
    Holz, B.
    Kron, A.
    Wolf, J.
    Merkelbach-Bruse, S.
    Reinhardt, C.
    Buettner, R.
    Schultheis, A. M.
    [J]. VIRCHOWS ARCHIV, 2018, 473 : S17 - S17
  • [6] Genetic screening and molecular characterization of MET alterations in non-small cell lung cancer
    M. Saigi
    A. McLeer-Florin
    E. Pros
    E. Nadal
    E. Brambilla
    M. Sanchez-Cespedes
    [J]. Clinical and Translational Oncology, 2018, 20 : 881 - 888
  • [7] Genetic screening and molecular characterization of MET alterations in non-small cell lung cancer
    Saigi, M.
    McLeer-Florin, A.
    Pros, E.
    Nadal, E.
    Brambilla, E.
    Sanchez-Cespedes, M.
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2018, 20 (07): : 881 - 888
  • [8] Multiplex RNA-based detection of clinically relevant MET alterations in advanced non-small cell lung cancer
    Aguado, Cristina
    Teixido, Cristina
    Roman, Ruth
    Reyes, Roxana
    Gimenez-Capitan, Ana
    Marin, Elba
    Cabrera, Carlos
    Vinolas, Nuria
    Castillo, Sergi
    Munoz, Silvia
    Arcocha, Ainara
    Lopez-Vilaro, Laura
    Sullivan, Ivana
    Aldeguer, Erika
    Rodriguez, Sonia
    Moya, Irene
    Viteri, Santiago
    Cardona, Andres Felipe
    Palmero, Ramon
    Sainz, Cristina
    Mesa-Guzman, Miguel
    Lozano, Maria D.
    Aguilar-Hernandez, Andres
    Martinez-Bueno, Alejandro
    Gonzalez-Cao, Maria
    Gonzalvo, Elena
    Leenders, William P. J.
    Rosell, Rafael
    Montuenga, Luis M.
    Prat, Aleix
    Molina-Vila, Miguel A.
    Reguart, Noemi
    [J]. MOLECULAR ONCOLOGY, 2021, 15 (02) : 350 - 363
  • [9] Targeting un-MET needs in advanced non-small cell lung cancer
    Coleman, Niamh
    Harbery, Alice
    Heuss, Sara
    Vivanco, Igor
    Popat, Sanjay
    [J]. LUNG CANCER, 2022, 164 : 56 - 68
  • [10] The Role of MET Inhibitor Therapies in the Treatment of Advanced Non-Small Cell Lung Cancer
    De Mello, Ramon Andrade
    Neves, Nathalia Moises
    Amaral, Giovanna Araujo
    Lippo, Estela Gudin
    Castelo-Branco, Pedro
    Pozza, Daniel Humberto
    Tajima, Carla Chizuru
    Antoniou, Georgios
    [J]. JOURNAL OF CLINICAL MEDICINE, 2020, 9 (06) : 1 - 16
12345